501 related articles for article (PubMed ID: 17661800)
1. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
Velioğlu SK; Gazioğlu S
Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
[TBL] [Abstract][Full Text] [Related]
2. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
3. Valproate-induced hyperammonemic encephalopathy.
Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
[TBL] [Abstract][Full Text] [Related]
4. Valproate-induced hyperammonemic encephalopathy: a brief review.
Lewis C; Deshpande A; Tesar GE; Dale R
Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
[TBL] [Abstract][Full Text] [Related]
5. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K
Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
[TBL] [Abstract][Full Text] [Related]
6. [Hyperammonaemic encephalopathy due to valproic acid].
Durán-Ferreras E; Jiménez-Vilches PL; Galá-Barranco JM; Fernández-Bolaños Porras R
Rev Neurol; 2008 May 1-15; 46(9):537-9. PubMed ID: 18446695
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of rapid IV administration of valproic acid for status epilepticus.
Rossetti AO; Bromfield EB
Neurology; 2005 Aug; 65(3):500-1; author reply 500-1. PubMed ID: 16087935
[No Abstract] [Full Text] [Related]
8. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
Tsai MF; Chen CY
Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
[TBL] [Abstract][Full Text] [Related]
9. [Hyperammonemic encephalopathy associated with valproate acid].
Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
[TBL] [Abstract][Full Text] [Related]
10. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
[TBL] [Abstract][Full Text] [Related]
11. Valproate-induced epileptic tonic status.
Capocchi G; Balducci A; Cecconi M; Pelli MA; Picchiarelli A; Silvestrelli G; Zampolini M
Seizure; 1998 Jun; 7(3):237-41. PubMed ID: 9700838
[TBL] [Abstract][Full Text] [Related]
12. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
13. Different clinical manifestations of hyperammonemic encephalopathy.
Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
[TBL] [Abstract][Full Text] [Related]
14. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
Mallet L; Babin S; Morais JA
Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
[TBL] [Abstract][Full Text] [Related]
16. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
Mehndiratta MM; Mehndiratta P; Phul P; Garg S
J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
Deutsch SI; Burket JA; Rosse RB
Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.
Kifune A; Kubota F; Shibata N; Akata T; Kikuchi S
Epilepsia; 2000 Jul; 41(7):909-12. PubMed ID: 10897167
[TBL] [Abstract][Full Text] [Related]
19. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
Vossler DG; Wilensky AJ; Cawthon DF; Kraemer DL; Ojemann LM; Caylor LM; Morgan JD
Epilepsia; 2002 Feb; 43(2):154-9. PubMed ID: 11903461
[TBL] [Abstract][Full Text] [Related]
20. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
